A Canadian Cancer Discovery
Categories:
A Canadian Cancer Discovery Researchers at Princess Margaret Cancer Centre have developed Porphysomes—light-activated nanoparticles designed to enhance cancer surgery and treatment. Now, with Health Canada’s approval, this Canadian innovation is moving from the lab to patient care. April 14, 2025 Share UHN-led innovation moves from lab to clinic with Health Canada approval for clinical trials. For over a decade, a team of researchers at Princess Margaret Cancer Centre has been advancing a revolutionary approach to cancer treatment...